ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO836

Severe Hyperparathyroidism Is Associated With Nutritional Impairment in Maintenance Hemodialysis Patients

Session Information

Category: Health Maintenance‚ Nutrition‚ and Metabolism

  • 1400 Health Maintenance‚ Nutrition‚ and Metabolism

Author

  • Disthabanchong, Sinee, Mahidol University Faculty of Medicine Ramathibodi Hospital Department of Medicine, Bangkok, Bangkok, Thailand
Background

Severe hyperparathyroidism predicts poor outcomes and parathyroidectomy is associated with improved survival in patients with kidney failure. Mechanisms underlying these observations have not been clearly elucidated. The issues regarding nutritional impairment in severe hyperparathyroidism have rarely been addressed. The present study examined nutritional status among maintenance hemodialysis (MHD) patients with different degree of hyperparathyroidism.

Methods

Seven hundred forty-five patients were categorized into four groups according to PTH levels: group 0, PTH<200; group 1, PTH=200-599; group 2, PTH=600-1499; and group 3, PTH≥1500 pg/mL. Group 0 was excluded because low PTH level was linked to older age and malnutrition. Patients in groups 1 and 2 were matched to group 3 by propensity score yielding 410 patients in the final analysis. Nutritional parameters at baseline (Year 0) and the preceding 1 and 2 years (Year -1 and Year -2) were analyzed.

Results

At baseline, lower serum albumin (P<0.001), creatinine (P<0.001), height in female (P=0.001), creatinine/body surface area (Cr/BSA) (P=0.001) and higher number of patients with serum albumin <38 g/L (P<0.001) were observed in group 3 compared to groups 1 and 2. Higher PTH level was independently associated with serum albumin <38 g/L (P<0.001) and serum Cr/BSA <380 μmol/L/m2 (P=0.001). Lower serum albumin, creatinine and Cr/BSA and higher number of patients with serum albumin <38 g/L were observed at Year 0 compared to Year -1 and Year -2 among patients in group 3. Between group comparisons confirmed a significant difference in serum albumin, the number of patients with serum albumin <38 g/L, serum creatinine and Cr/BSA between baseline and the preceding 1 and 2 years in group 3 compared to groups 1 and 2. The number of patients with Cr/BSA <380 μmol/L/m2 was also significantly different between baseline and the preceding 1 and 2 years in group 3 compared to group 1. Weight loss was more substantial in group 3 compared to group 2 (P=0.03) and the number of patients with ≥5% weight loss was higher in group 3 compared to groups 1 (P=0.005) and 2 (P=0.03).

Conclusion

MHD patients with severe hyperparathyroidism had deterioration of nutritional status compared to patients with moderate hyperparathyroidism and patients with PTH level within the recommended range.